BSE filing, NSE: RUNWALENTR. Summary written from the filing by ALFA Finder's alert engine.
Runwal Enterprises Ltd: key numbers
- Share price
- ₹216.42
- Market cap
- ₹3,198 Cr
- Revenue (annual)
- ₹1,799 Cr
- Net profit (annual)
- ₹209.3 Cr
- Promoter holding
- 84.61%
- FII holding
- 1.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Runwal Enterprises Ltd
All →Runwal Enterprises Board Meeting Date
Runwal Enterprises Limited has given prior intimation of a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. No financial figures are disclosed in this notice.
Runwal Enterprises Earnings Call Transcript: Key Takeaways
Runwal Enterprises debuted its first earnings call as a listed entity, focusing on debt reduction via IPO proceeds and land monetization. Management is pivoting toward luxury and annuity assets to drive higher margins.
Runwal Enterprises Q1 FY27 Results: Net Profit ₹49.8 Cr, Down 65.2% YoY
Runwal Enterprises Ltd reported revenue from operations of ₹338.2 Cr (-24.2% YoY) and net profit of ₹49.8 Cr (-65.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹49.8 Cr · -65.2% YoY
Runwal Enterprises Board Meeting Date
Runwal Enterprises Ltd has scheduled a board meeting on October 23, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Runwal Enterprises Debt & Borrowing: ₹50 Cr
Runwal Enterprises Ltd executed a Debenture Subscription Agreement to invest ₹50 Crore in its subsidiary via NCDs for debt repayment.
- Value
- ₹50.00 Cr
Runwal Enterprises Debt & Borrowing: ₹175 Cr
Runwal Enterprises Ltd will subscribe to ₹175 Crore worth of Non-Convertible Debentures issued by its subsidiary, Runwal Residency Private Limited, to support debt repayment.
- Value
- ₹175.0 Cr
Other other announcement announcements
All →Fundviser Capital (India) Other Announcement
Fundviser Capital's quarterly Regulation 32 statement confirms no deviation in use of preferential warrant proceeds. Funds utilised total ₹38.10 Crore against ₹79.44 Crore raised.
Austere Systems Other Announcement
Austere Systems appointed EquiBridgeX Advisors as its Investor Relations and Public Relations agency effective November 5, 2026. The filing states no fees or financial terms.
Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Span Divergent Other Announcement
Span Divergent approved leasing Ahmedabad property to material subsidiary Dryfruit Factory LLP. Rent is capped at ₹3 lakh monthly under an arm's-length related-party transaction.